CompletedNCT00223210
Quetiapine added for bipolarity with cocaine dependence
About this title
An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence
Read the official source — NCT00223210Medication studyAges 18–60United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
- Listed locations
- DallasSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateNovember 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 100
- Sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT00223210
- Official title
Show the full official title
A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedDallas
Questions about this study
Who is behind this study?
The study sponsor is University of Texas Southwestern Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including Quetiapine and PLacebo.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
